Vertex Pharmaceuticals Incorporated
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Vertex Pharmaceuticals Incorporated's balance sheet done over the years? Its assets were worth $22,730,200,000 last year, which is more than in the previous period. 23% of Vertex Pharmaceuticals Incorporated’s total assets is currently financed by debt. Its liabilities reached the amount of $5,149,800,000, which means an increase by 22% compared compared to last year.
Debt to Assets
| 2014 | 2336309000 | 1.24B | 53.08% |
|---|---|---|---|
| 2015 | 2497045000 | 1.40B | 56.24% |
| 2016 | 2893785000 | 1.55B | 53.76% |
| 2017 | 3546014000 | 1.50B | 42.41% |
| 2018 | 6245898000 | 1.81B | 28.99% |
| 2019 | 8318465000 | 2.23B | 26.85% |
| 2020 | 11751808000 | 3.06B | 26.08% |
| 2021 | 13432500000 | 3.33B | 24.81% |
| 2022 | 18150900000 | 4.23B | 23.35% |
| 2023 | 22730200000 | 5.14B | 22.66% |
0QZU.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 10.36B | 10.50B | 6.79B | 5.98B | 3.10B | 2.65B | 1.66B | 1.18B | 714.76M | 625.25M |
Short term investments | 849.2M | 274.5M | 729.9M | 670.71M | 698.97M | 518.10M | 423.25M | 250.61M | 327.69M | 761.84M |
Net receivables | 1.56B | 1.44B | 1.13B | 885.35M | 633.51M | 409.68M | 281.34M | 201.08M | 188.52M | 90.05M |
Inventory | 738.8M | 460.6M | 353.1M | 280.77M | 167.50M | 124.36M | 111.83M | 77.60M | 56.08M | 30.84M |
Other current assets | 623.7M | 74.4M | 187.2M | 308.35M | 213.51M | 74.04M | 126.43M | 16.78M | 118.96M | 38.5M |
Total current assets | 14.14B | 12.68B | 9.01B | 7.82B | 4.60B | 3.70B | 2.48B | 1.76B | 1.35B | 1.54B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.45B | 1.10B | 1.09B | 958.53M | 745.08M | 812.00M | 789.43M | 698.36M | 697.71M | 715.81M |
Goodwill | 1.08B | 1.08B | 1.40B | 1.40B | 1.40B | 50.38M | 50.38M | 50.38M | 50.38M | 39.91M |
Intangible assets | 839.9M | 603.6M | 400M | 400M | 400M | 0 | 29M | 284.34M | 284.34M | 29M |
Long term investments | 2.59B | 99.4M | 85.8M | 20.8M | 44.15M | 0 | 20.44M | 20.27M | 52.08M | 0 |
Other non-current assets | 796.7M | 1.32B | 901.1M | 662.51M | 326.94M | 181.54M | 193.86M | 99.69M | 109.51M | 3.44M |
Total non-current assets | 8.58B | 5.46B | 4.41B | 3.92B | 3.70B | 2.54B | 1.06B | 1.13B | 1.14B | 788.16M |
Total assets | 22.73B | 18.15B | 13.43B | 11.75B | 8.31B | 6.24B | 3.54B | 2.89B | 2.49B | 2.33B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 170.3M | 159.6M | 171.7M | 191.51M | 62.33M | 554.08M | 237.57M | 79.42M | 16.29M | 17.46M |
Short term debt | 83.7M | 89.4M | 46.9M | 42.43M | 30.29M | 9.81M | 45.06M | 319.42M | 86.84M | 49.81M |
Total current liabilities | 3.54B | 2.43B | 1.87B | 1.56B | 1.20B | 715.48M | 807.26M | 7.95M | 506.34M | 368.25M |
| Non-current liabilities: | ||||||||||
Long term debt | 1.44B | 471.6M | 556.7M | 581.47M | 577.37M | 567.16M | 583.90M | 838.24M | 739.39M | 792.93M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 153M | 1.33B | 902.2M | 923.40M | 451.32M | 528.05M | 104.47M | 562.69M | 39.24M | 34.45M |
Total non-current liabilities | 1.60B | 1.80B | 1.45B | 1.50B | 1.02B | 1.09B | 1.50B | 1.54B | 1.40B | 1.24B |
Total liabilities | 5.14B | 4.23B | 3.33B | 3.06B | 2.23B | 1.81B | 1.50B | 1.55B | 1.40B | 1.24B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |